An, Senyou
Yu, Huidan
Islam, MD Mahfuzul
Zhang, Xiaoyu
Zhan, Yuting
Olivieri, Joseph J.
Ambati, Jayakrishna
Yao, Jun
Gelfand, Bradley D.
Funding for this research was provided by:
BrightFocus Foundation (076376-00002B)
National Science Foundation (ACI-1548562)
Indiana University-Purdue University Indianapolis (Research Development Fund (IRDF))
IUPUI University Fellowship
National Institutes of Health (R01EY031039)
National Natural Science Foundation of China (51490654, 51711530131, 51674280)
Program of Innovation Projects (YCXJ2016021)
Owens Family Foundation
Article History
Received: 16 May 2023
Accepted: 28 November 2023
First Online: 19 December 2023
Competing interests
: The authors declare no competing interests. J.A. and B.D.G. are named as inventors on patent applications on macular degeneration filed by the University of Kentucky and University of Virginia unrelated to this work. J.A. and B.D.G. are co-founders of DiceRx. J.A. is a co-founder of iVeena Holdings, iVeena Delivery Systems, and Inflammasome Therapeutics, and has been a consultant for Allergan, Boehringer-Ingelheim, Retinal Solutions, and Saksin LifeSciences unrelated to this work.